We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cell Culture of Glioma Specimens for in Vitro Preclinical Studies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01125826
Recruitment Status : Unknown
Verified April 2009 by Albany Medical College.
Recruitment status was:  Recruiting
First Posted : May 19, 2010
Last Update Posted : June 27, 2011
Sponsor:
Information provided by:

Study Description
Brief Summary:

The purpose of this study is to culture primary human brain tumor cells with the specific aims of:

  1. Develop primary cultures from human brain tumor surgical specimens
  2. Determine the genetic and molecular fingerprints of brain tumors that may have prognostic significance
  3. Delineate the mechanisms underlying oncogenesis of brain tumors.
  4. Perform in vitro assays with brain tumor derived primary cultures to assess the efficacy of novel therapeutic agents.

Condition or disease
Brain Tumor

Study Design

Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Primary Cell Culture of Surgical Glioma Specimens for Invitro Preclinical Studies
Study Start Date : April 2009
Estimated Primary Completion Date : April 2012
Estimated Study Completion Date : June 2012

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Biospecimen Retention:   Samples Without DNA
All subjects will be give permission for specimen storage by signing a separate permission on the informed consent. All specimens will be stored at a tissue bank for an unspecified amount of time.

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients 18 years of age or older undergoing surgical resection for gliomas.
Criteria

Inclusion Criteria:

  • Patients 18 years of age or older undergoing surgical resection for glioma

Exclusion Criteria:

  • Under 18 years of age
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01125826


Contacts
Contact: Yu-Hung Kuo, MD 518 262 5088 kuoy@mail.amc.edu

Locations
United States, New York
Albany Medical Center Recruiting
Albany, New York, United States, 12208
Contact: Tyler Kenning, MD       kennint@mail.amc.edu   
Sponsors and Collaborators
Albany Medical College
More Information

Responsible Party: Yu-Hung Kuo, MD, Neurosciences Institute, Albany Medical College
ClinicalTrials.gov Identifier: NCT01125826     History of Changes
Other Study ID Numbers: 2536
First Posted: May 19, 2010    Key Record Dates
Last Update Posted: June 27, 2011
Last Verified: April 2009